These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 30230756)

  • 1. PORTAL HYPERTENSION TREATMENT WITH CANDESARTAN PLUS PROPRANOLOL FOR NINE MONTHS RESTORES NORMAL PORTAL CIRCULATION HEMODYNAMIC PATTERN.
    Abd Alla MD; Eid EMM; Soliman AIA; Elhawary MA; Kilany YF; Abd-Almonaem G; Bayoumi SS; Moursy MRA; Al-Zaem FAM
    J Egypt Soc Parasitol; 2016 Dec; 46(3):587-604. PubMed ID: 30230756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of candesartan and propranolol combination therapy versus propranolol monotherapy in reducing portal hypertension.
    Kim JH; Kim JM; Cho YZ; Na JH; Kim HS; Kim HA; Kang HW; Baik SK; Kwon SO; Cha SH; Kim YJ; Kim MY
    Clin Mol Hepatol; 2014 Dec; 20(4):376-83. PubMed ID: 25548744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Damping index of Doppler hepatic vein waveform to assess the severity of portal hypertension and response to propranolol in liver cirrhosis: a prospective nonrandomized study.
    Kim MY; Baik SK; Park DH; Lim DW; Kim JW; Kim HS; Kwon SO; Kim YJ; Chang SJ; Lee SS
    Liver Int; 2007 Oct; 27(8):1103-10. PubMed ID: 17845539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irbesartan plus low-dose propranolol versus low-dose propranolol alone in cirrhosis: a placebo-controlled, double-blind study.
    Schepke M; Wiest R; Flacke S; Heller J; Stoffel-Wagner B; Herold T; Ghauri M; Sauerbruch T
    Am J Gastroenterol; 2008 May; 103(5):1152-8. PubMed ID: 18422814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long term effects of propranolol on portal pressure in cirrhotic patients.
    Orban-Schiopu AM; Popescu CR
    Rom J Gastroenterol; 2003 Mar; 12(1):25-30. PubMed ID: 12673376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute administration of carvedilol is more effective than propranolol plus isosorbide-5-mononitrate in the reduction of portal pressure in patients with viral cirrhosis.
    Lin HC; Yang YY; Hou MC; Huang YT; Lee FY; Lee SD
    Am J Gastroenterol; 2004 Oct; 99(10):1953-8. PubMed ID: 15447755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of propranolol and depot lanreotide SR on postprandial and circadian portal haemodynamics in cirrhosis.
    Schiedermaier P; Koch L; Stoffel-Wagner B; Layer G; Sauerbruch T
    Aliment Pharmacol Ther; 2003 Oct; 18(8):777-84. PubMed ID: 14535870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of a combined treatment with propranolol and isosorbide-5-mononitrate on Doppler ultrasound parameters in patients with cirrhosis and portal hypertension.
    Orban Schiopu AM; Balas BI; Diculescu M
    Rom J Gastroenterol; 2005 Jun; 14(2):123-7. PubMed ID: 15990930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative randomized study on efficacy of losartan versus propranolol in lowering portal pressure in decompensated chronic liver disease.
    Agasti AK; Mahajan AU; Phadke AY; Nathani PJ; Sawant P
    J Dig Dis; 2013 May; 14(5):266-71. PubMed ID: 23280243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative portal hypotensive effects as propranolol of vitamin D₃ treatment by decreasing intrahepatic resistance in cirrhotic rats.
    Lee PC; Yang YY; Lee WP; Lee KC; Hsieh YC; Lee TY; Lin HC
    J Gastroenterol Hepatol; 2015 Mar; 30(3):628-37. PubMed ID: 25187428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rifaximin and Propranolol Combination Therapy Is More Effective than Propranolol Monotherapy for the Reduction of Portal Pressure: An Open Randomized Controlled Pilot Study.
    Lim YL; Kim MY; Jang YO; Baik SK; Kwon SO
    Gut Liver; 2017 Sep; 11(5):702-710. PubMed ID: 28651304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Portal pressure response to losartan compared with propranolol in patients with cirrhosis.
    De BK; Bandyopadhyay K; Das TK; Das D; Biswas PK; Majumdar D; Mandal SK; Ray S; Dasgupta S
    Am J Gastroenterol; 2003 Jun; 98(6):1371-6. PubMed ID: 12818283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of effects of propranolol on portal hemodynamics in cirrhosis by duplex ultrasonography.
    Saigal S; Chawla Y; Dilawari JB
    Indian J Gastroenterol; 1998 Apr; 17(2):51-2. PubMed ID: 9563219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoscopic, portographic, and hemodynamic evaluation of prolonged propranolol administration in pigs with experimental portal hypertension and esophageal varices.
    Jensen LS; Krarup N; Juhl CO; Nielsen TH; Larsen JA
    Scand J Gastroenterol; 1989 Mar; 24(2):213-22. PubMed ID: 2928736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined treatment of portal hypertension with ritanserin and propranolol in conscious and unrestrained cirrhotic rats.
    Pomier-Layrargues G; Giroux L; Rocheleau B; Huet PM
    Hepatology; 1992 May; 15(5):878-82. PubMed ID: 1568730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic effects of chronic tetrandrine and propranolol administration on portal hypertensive rats.
    Huang YT; Liu TB; Lin HC; Yang MC; Hong CY
    Pharmacology; 1997 May; 54(5):225-31. PubMed ID: 9380768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of atorvastatin on portal hemodynamics and clinical outcomes in patients with cirrhosis with portal hypertension: a proof-of-concept study.
    Bishnu S; Ahammed SM; Sarkar A; Hembram J; Chatterjee S; Das K; Dhali GK; Chowdhury A; Das K
    Eur J Gastroenterol Hepatol; 2018 Jan; 30(1):54-59. PubMed ID: 29099421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the combined administration of propranolol plus sorafenib on portal hypertension in cirrhotic rats.
    D'Amico M; Mejías M; García-Pras E; Abraldes JG; García-Pagán JC; Fernández M; Bosch J
    Am J Physiol Gastrointest Liver Physiol; 2012 May; 302(10):G1191-8. PubMed ID: 22403792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the adjunctive probiotic VSL#3 on portal haemodynamics in patients with cirrhosis and large varices: a randomized trial.
    Gupta N; Kumar A; Sharma P; Garg V; Sharma BC; Sarin SK
    Liver Int; 2013 Sep; 33(8):1148-57. PubMed ID: 23601333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Captopril reduces portal pressure effectively in portal hypertensive patients with low portal venous velocity.
    Baik SK; Park DH; Kim MY; Choi YJ; Kim HS; Lee DK; Kwon SO; Kim YJ; Park JW; Chang SJ
    J Gastroenterol; 2003; 38(12):1150-4. PubMed ID: 14714252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.